• 2124 Citations
  • 23 h-Index
19932018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Cesare Astori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 33 Similar Profiles
Primary Myelofibrosis Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Calreticulin Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2018

  • 2124 Citations
  • 23 h-Index
  • 55 Article
  • 1 Review article
1 Citation (Scopus)

Diagnosis and management of prefibrotic myelofibrosis

on Behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators, Jul 3 2018, In : Expert Review of Hematology. 11, 7, p. 537-545 9 p.

Research output: Contribution to journalReview article

Primary Myelofibrosis
Essential Thrombocythemia
Splenomegaly
Leukocytosis
L-Lactate Dehydrogenase
11 Citations (Scopus)

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

Rumi, E., Boveri, E., Bellini, M., Pietra, D., Ferretti, V. V., Sant'Antonio, E., Cavalloni, C., Casetti, I. C., Roncoroni, E., Ciboddo, M., Benvenuti, P., Landini, B., Fugazza, E., Troletti, D., Astori, C., Cazzola, M. & on Behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators, Jan 1 2017, In : Oncotarget. 8, 60, p. 101735-101744 10 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Primary Myelofibrosis
Splenomegaly
Platelet Count
Leukocyte Count
3 Citations (Scopus)

Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms

Cavalloni, C., Rumi, E., Ferretti, V. V., Pietra, D., Roncoroni, E., Bellini, M., Ciboddo, M., Casetti, I. C., Landini, B., Fugazza, E., Troletti, D., Astori, C. & Cazzola, M., Jan 1 2017, In : Oncotarget. 8, 20, p. 33416-33421 6 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Primary Myelofibrosis
Neoplasms
Alleles
Multivariate Analysis
93 Citations (Scopus)

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms

Pietra, D., Rumi, E., Ferretti, V. V., Di Buduo, C. A., Milanesi, C., Cavalloni, C., Sant'Antonio, E., Abbonante, V., Moccia, F., Casetti, I. C., Bellini, M., Renna, M. C., Roncoroni, E., Fugazza, E., Astori, C., Boveri, E., Rosti, V., Barosi, G., Balduini, A. & Cazzola, M., Feb 1 2016, In : Leukemia. 30, 2, p. 431-438 8 p.

Research output: Contribution to journalArticle

Calreticulin
Mutation
Essential Thrombocythemia
Primary Myelofibrosis
Neoplasms

LNK mutations in familial myeloproliferative neoplasms

Rumi, E., Harutyunyan, A. S., Pietra, D., Feenstra, J. D. M., Cavalloni, C., Roncoroni, E., Casetti, I., Bellini, M., Milanesi, C., Renna, M. C., Gotti, M., Astori, C., Kralovics, R. & Cazzola, M., Jul 7 2016, In : Blood. 128, 1, p. 144-5 2 p.

Research output: Contribution to journalArticle